Healthtech funding in H2 2019
European Healthtech startup funding raised during H2 2019.
In H2 2019, 179 European Healthtech companies closed 179 funding rounds and raised €2.0B in equity funding (excluding debt and grants), up 47.6% versus H2 2018. UK led by capital raised, and Almi Invest was the most active investor. Data as of 20 Nov 2026.
Equity funding
€2.0B
+47.6% vs H2 2018 · excl. debt & grants
Funding rounds
179
+43.2% vs H2 2018
Companies
179
Top country
UK
Rank among sectors
#4
9.8% of sector funding
Top-10 round share
54.6%
of disclosed capital
Rounds ≥ €100M
2
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, H2 2019 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jul | €1.0B | 37 |
| Aug | €1.1M | 1 |
| Oct | €1.0B | 139 |
| Dec | €1.0M | 2 |
Top countries
by € raisedHealthtech — top countries by capital, H2 2019 — interactive chart.
Data table
| Healthtech — top countries by capital, H2 2019 | |
|---|---|
| UK | €1.0B |
| Israel | €293M |
| France | €213M |
| Germany | €155M |
| Switzerland | €139M |
| Belgium | €55M |
| Spain | €34M |
| Sweden | €32M |
Stage mix
by € raisedHealthtech — stage mix, H2 2019 — interactive chart.
Data table
| Healthtech — stage mix, H2 2019 | |
|---|---|
| Other | €704M |
| Series B | €395M |
| Series C | €394M |
| Series A | €238M |
| Series D+ | €180M |
| Seed | €70M |
| Grant | €9.1M |
| Pre-Seed | €3.0M |
Exits & M&A
10 Acquisition10 exits · €411M disclosed.
| Amal Therapeutics | Acquisition | Nov 2019 | €325M |
| 6over6 | Acquisition | Oct 2019 | €86M |
Top deals
largest disclosed rounds in H2 2019| Company | Stage | Date | Amount |
|---|---|---|---|
| Babylon | Other | Jul 2019 | €483M |
| CMR Surgical | Series C | Jul 2019 | €218M |
| Ottonova | Series D+ | Oct 2019 | €60M |
| Healthy.io | Series C | Oct 2019 | €55M |
| Healx | Series B | Oct 2019 | €51M |
| Imcheck Therapeutics | Series B | Oct 2019 | €49M |
| Viz.ai | Series B | Oct 2019 | €46M |
| PolyPid | Series D+ | Jul 2019 | €44M |
| Quanta | Series C | Jul 2019 | €42M |
| iSTAR Medical | Series C | Jul 2019 | €40M |
| inotrem | Series B | Oct 2019 | €39M |
| anokion | Series B | Oct 2019 | €37M |
| Azeria Therapeutics | Series B | Oct 2019 | €36M |
| Xact Robotics | Series D+ | Oct 2019 | €33M |
| Diabeloop | Series B | Oct 2019 | €31M |
Top investors
most active in H2 2019, by deal count- Almi Invest2 deals
- aMoon Fund2 deals
- Bpifrance2 deals
- btov Partners2 deals
- LSP2 deals
- Pfizer Ventures2 deals
- Sofinnova Partners2 deals
- Adrea1 deals
- ADV1 deals
- Agronomics1 deals